As debates around patient waivers for COVID-19 vaccines rages on, our Editor, Stephanie Sutton, examines the fairness of the current approach to vaccine distribution. Let us know your opinion on the topic here. You can find Stephanie’s take on the issue below. Be sure to take a look at our stories too.
Weekly Spotlight

Be The Match BioTherapies® is the only cell and gene therapy solutions provider with optimized services to support any stage of the supply chain, from the point of patient identification through cell harvest, therapeutic intervention and long-term outcomes data collection.

 

About Be The Match BioTherapies
 
COVID-19
What Do We Do About Distribution?
06/14/2021 | Stephanie Vine
COVID-19 vaccine rollout is a lottery, with some countries faring much better than others.
DRUG DELIVERY
A Tailored Solution
06/12/2021 | Maryam Mahdi
Can drug delivery be redefined using polymeric threads?
ADVANCED MEDICINE
Results That Last
06/23/2021 | Maryam Mahdi
Could zinc finger therapy hold the key to treating Alzheimer’s disease?
ADVANCED MEDICINE
What's New from the Cell + Gene Curator?
06/11/2021 | James Strachan
What was described by a University of California professor as gene therapy's "single most remarkable achievement?"
 
Webinar
Smart Shipping Solutions For Cell Therapy Logistics

Our webinar with Cytiva on overcoming cell therapy logistics without the hazards of liquid nitrogen is now available to view on demand. Stream now
 
White Papers
Early Stage Product Development Using Laser Diffraction Analysis

Particle size and size distribution are often important parameters in defining product performance. Read more
Measuring Degradation Related Changes in Molecular Weight and Rheology During Processing

Polycaprolactone (PCL) is a synthetic polymer that has recently received increasing attention thanks to its biodegradability. Read more
 
Product Profile
Integrated and Flexible Clinical Supply Solutions

Catalent is a global leader in clinical supply services, with flexible solutions for small molecules, biologics, cell and gene therapies, and integrated services to accelerate speed to clinic. Learn more
 
Special Promotion
How to Accelerate Lot-Release and In-Process Mycoplasma Testing

PCR-based mycoplasma testing for lot-release of biotherapeutics has grown in acceptability by regulatory agencies worldwide. Learn about regulatory guidance and considerations for manufacturers who want to shift to a rapid assay. Find out more
 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.
Find out more
This email was sent to {~email~} by info@themedicinemaker.com. To ensure delivery of emails to your inbox, please add info@themedicinemaker.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Medicine Maker is a brand of Texere Publishing Limited (trading as Conexiant)

Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.